Health Care & Life Sciences » Medical Equipment & Supplies | Mainstay Medical International PLC

Mainstay Medical International PLC | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
308.50
562
Cost of Goods Sold (COGS) incl. D&A
711.80
2,999.00
3,946.20
5,061.50
168.40
304.30
Gross Income
711.80
2,999.00
3,946.20
5,061.50
140.10
257.70
SG&A Expense
5,612.30
5,384.30
7,654.30
10,151.00
24,715.10
25,080.70
EBIT
6,324.10
8,383.30
11,600.50
15,212.50
24,575.00
24,823.10
Unusual Expense
580.70
53,155.60
-
-
-
-
Non Operating Income/Expense
37.70
33.90
47.80
96.70
40.80
167.80
Interest Expense
2,042.00
553.40
243.50
1,537.70
1,712.90
1,434.20
Pretax Income
7,747.70
62,126.20
11,891.70
16,846.90
26,247.10
26,425.10
Income Tax
24.10
43.70
43.30
110.30
203.90
83.10
Consolidated Net Income
7,771.80
62,169.90
11,935.00
16,957.20
26,451.00
26,342
Net Income
7,771.80
62,169.90
11,935.00
16,957.20
26,451.00
26,342
Net Income After Extraordinaries
7,771.80
62,169.90
11,935.00
16,957.20
26,451.00
26,342
Net Income Available to Common
7,771.80
62,169.90
11,935.00
16,957.20
26,451.00
26,342
EPS (Basic)
6.91
21.18
2.78
3.06
4.00
3.10
Basic Shares Outstanding
1,125.70
2,935.30
4,294.60
5,548.90
6,615.40
8,505
EPS (Diluted)
6.90
21.18
2.78
3.06
4.00
3.10
Diluted Shares Outstanding
1,125.70
2,935.30
4,294.60
5,548.90
6,615.40
8,505
EBITDA
6,306.80
8,359.20
11,530.10
15,104.00
24,480.20
24,747.60

About Mainstay Medical International

View Profile
Address
Clonmel House
Dublin Dublin
Ireland
Employees -
Website http://www.mainstay-medical.com
Updated 07/08/2019
Mainstay Medical International Plc is a medical device company, which is engaged in the development of neurostimulation therapies. The company's focus is on the development of ReActiv8, a medical device designed to treat people with chronic low back pain. The company was founded on February 17, 2014 and is headquartered in Dublin, Ireland.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.